[{"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["ECOLAB INC."], "generic_name": ["CHLOROXYLENOL"], "manufacturer_name": ["Ecolab Inc."], "product_ndc": ["47593-503"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["436367"], "spl_id": ["2ec496ad-2044-439f-a834-13bda7839e52"], "spl_set_id": ["74373f6b-f407-455e-93a1-b0fd31e40718"], "package_ndc": ["47593-503-41", "47593-503-59"], "is_original_packager": [true], "upc": ["0025469012111"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "81510", "recalling_firm": "Ecolab Inc", "address_1": "Level 7 370 N", "address_2": "N/A", "postal_code": "55102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0275-2019", "product_description": "Medi-Stat Foam, Antimicrobial Hand Soap, Chloroxylenol 0.5%, 1250 mL (42.3 fl oz), OTC, Ecolab, 370 Wabasha Street N, St. Paul, MN 55102, NDC 47593-503-59", "product_quantity": "14,108 bottles", "reason_for_recall": "Labeling: Label mix-up -  the label on the product may not match the formula in the bottle.", "recall_initiation_date": "20181109", "center_classification_date": "20181120", "termination_date": "20201106", "report_date": "20181128", "code_info": "Lot#: L062281, Exp 06/20", "more_code_info": ""}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0313-2019", "product_description": "Valsartan Tablets, USP, 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5813-77.", "product_quantity": "24,709 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3063782, exp. date 1/2019"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1208-2018", "product_description": "Minivelle (estradiol transdermal system) Patches, Delivers 0.05 mg/day, a) 2 count and 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6650-8", "product_quantity": "149631 boxes of 8 patches and 15809 boxes of 2 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "a) 82292 Exp. 02/2019;    b) 82139 Exp. 10/2018; 82292 Exp. 02/2019; and 82598 Exp. 04/2019", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C261 BUD: 12/20/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 12.5mg pellet, 1 count (NDC 69761-112-01), 6 count (NDC 69761-112-06), 12 count (NDC 69761-112-12), and 30 count (NDC 69761-112-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0232-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81684", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0348-2019", "product_description": "NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771", "product_quantity": "4,065,550 5 ml cups", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification for impurities.", "recall_initiation_date": "20181130", "center_classification_date": "20190107", "termination_date": "20201125", "report_date": "20181226", "code_info": "Lots:   a) 505300 Exp. Dec 2018; 522200 Exp. Apr 2019; 534400 Exp. Jul 2019;  539000 Exp. Aug 2019; 543400 Exp. Sep 2019;   b) 523600, 522200X Exp. Apr 2019; 535500 Exp. Jul 2019; 540700 Exp. Aug 2019; 543300 Exp. Sep 2019; 550100 Exp. Oct 2019.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0137-2019", "product_description": "Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1414-20", "product_quantity": "7150 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 04112018:83 Discard by: 10/8/2018; 03202018:48 Discard by: 9/16/2018; 04302018:91 Discard by: 10/27/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0177-2019", "product_description": "QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1342-05", "product_quantity": "25 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 07242018:90 Discard by: 1/20/2019"}, {"status": "Terminated", "city": "Olive Branch", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81668", "recalling_firm": "Westminster Pharmaceuticals Llc", "address_1": "1 & 2", "address_2": "154 Downing Street", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0302-2019", "product_description": "Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-121-01; b) 90 count bottle NDC 69367-121-03", "product_quantity": "3976 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed traces of NDEA  impurity in specific lots of Irbesartan.", "recall_initiation_date": "20181029", "center_classification_date": "20181214", "termination_date": "20211026", "report_date": "20181219", "code_info": "Batch Numbers: a) B162008A Exp. 09/30/2019, C162002A Exp. 02/29/2020; b) B162008B Exp. 09/30/2019, C162002B Exp. 02/29/2020"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0102-2019", "product_description": "PIO&METFORMIN 15/1000 mg Tab 1 (Pioglitazone and Metformin XT) tablets, Takeda Brand Name: Actoplus Met XR (Pioglitazone and metformin HCl extended -release) tablets, 15 mg/1000 mg, packaged in a fiber drum, Application Holder Takeda Pharmaceuticals, U.S.A. Inc. One Takeda Parkway, Deerfield, IL 60015", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Bulk Lot no 1250668, 15 mg/1000 mg Bulk product No # 1274150, no NDC Codes, bulk exp. date 05/2020 & 10/2020"}, {"country": "United States", "city": "Fort Worth", "address_1": "4201 Diplomacy Rd", "reason_for_recall": "Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.", "address_2": "", "product_quantity": "2055 tubes", "code_info": "Lot #: 129114 Exp. 06/2019; 131927,133239 Exp. 03/2020; 126292, Exp.01/2019.", "center_classification_date": "20181220", "distribution_pattern": "United States, Maldives, Canada, United Arab Emirates, and New Zealand", "state": "TX", "product_description": "Options Rx Anti-Oxidant Oil-Free Sunscreeen (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 oz./128 g tube, Mfg. For Credentials Skincare Fort Worth, TX 76155", "report_date": "20181226", "classification": "Class III", "openfda": {}, "recalling_firm": "CBI Laboratories, Inc.", "recall_number": "D-0342-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81775", "termination_date": "20200114", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "76155-2633", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0161-2019", "product_description": "HCG 3000 Unit Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1738-10", "product_quantity": "765 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03262018:79 Discard by: 9/22/2018; 08212018:75 Discard by: 2/17/2019"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: D007 BUD: 01/09/2019; D060 BUD: 3/14/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 6 mg pellet, 1 count (NDC 69761-006-01), 6 count (NDC 69761-006-06), 12 count (NDC 69761-006-12), and 30 count (NDC 69761-006-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0230-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0039-2019", "product_description": "Harmon Face Values, Saline Nasal Gel with Soothing Aloe, 0.5 oz. (14.1 g) tube, Distributed by: Harmon Stores, Inc., Union, NJ 07083 USA, UPC 7 27510 00474 7 .", "product_quantity": "5040 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0058-2019", "product_description": "Best Choice, 12 Hour No-Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) Nasal Decongestant, 1 FL OZ (30 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC 0 70038 59895 4.", "product_quantity": "3,600 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086223"], "brand_name": ["ISOSORBIDE DINITRATE"], "generic_name": ["ISOSORBIDE DINITRATE"], "manufacturer_name": ["Sandoz Inc."], "product_ndc": ["0781-1556", "0781-1635", "0781-1695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOSORBIDE DINITRATE"], "rxcui": ["206842", "314055", "381056"], "spl_id": ["9c848a4f-2720-4c80-a0be-e49200cb10f9"], "spl_set_id": ["71fdd147-a987-40b6-9f07-82d56525ceb8"], "package_ndc": ["0781-1635-10", "0781-1635-01", "0781-1635-13", "0781-1556-01", "0781-1556-05", "0781-1556-10", "0781-1556-13", "0781-1695-13", "0781-1695-10", "0781-1695-01"], "is_original_packager": [true], "upc": ["0307811556017", "0307811695013", "0307811635019"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["IA7306519N"]}, "product_type": "Drugs", "event_id": "81457", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0258-2019", "product_description": "Isosorbide Dinitrate Tablets, USP 20 mg, 100-count bottles, Rx Only, Distributed by: Sandoz Inc. Princeton, NJ 08540; NDC 0781-1695-01", "product_quantity": "18,832 bottles", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20201002", "report_date": "20181121", "code_info": "Lots: a) JA9535 Exp. 05/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["REFRESH ANTIBAC FOAM"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["SC Johnson Professional USA, Inc."], "product_ndc": ["11084-010"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1046593"], "spl_id": ["ebf3eb0f-7d6a-42c0-9a1c-3eee60202dad"], "spl_set_id": ["884d1c8c-5643-423e-8ed4-d2ef38f8af73"], "package_ndc": ["11084-010-40", "11084-010-27", "11084-010-12", "11084-010-20", "11084-010-05", "11084-010-01", "11084-010-55", "11084-010-96", "11084-010-66"], "is_original_packager": [true], "upc": ["0069124050070"], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "81453", "recalling_firm": "S.C. Johnson Professional", "address_1": "2815 Coliseum Centre Dr Ste 600", "address_2": "", "postal_code": "28217-0144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC", "recall_number": "D-0220-2019", "product_description": "deb stoko, Refresh AntiBac FOAM (benzalkonium chloride), 0.13%, 1 L (33.8 fl. oz.) cartridge packaged in 8 cartridges per case, Made in the USA, Deb USA, Inc., Charlotte, NC  28217, NDC 11084-010-27.", "product_quantity": "869 cases", "reason_for_recall": "CGMP Deviations: Product was released to market prior to microbiological testing.", "recall_initiation_date": "20181026", "center_classification_date": "20181106", "termination_date": "20200908", "report_date": "20181114", "code_info": "Lot 9131", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0201-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/60 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1367-02", "product_quantity": "430 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06132018:87 Discard by: 12/10/2018; 05302018:66 Discard by: 11/25/2018; 06122018:54 Discard by: 11/17/2018; 07252018:88 Discard by: 1/21/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0044-2019", "product_description": "Premier Value Nasal Decongestant Extra Moisturizing Nasal Spray (Oxymetazoline HCl 0.05%), 1 FL OZ (30 mL) bottle, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 68016-304-03, UPC 8 40986 01518 2.", "product_quantity": "8592 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0146-2019", "product_description": "Calcium Gluconate 1% Eyewash Oph. Soln, 10 mg/mL, 1000 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0907-10", "product_quantity": "25 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 05072018:27 Discard by: 5/2/2019; 07122018:11 Discard by 7/7/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0110-2019", "product_description": "Bone Builder, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0012-1 and Tester NDC 61096-1012-1", "product_quantity": "731 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "West Jordan", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81556", "recalling_firm": "CAO Group, Inc.", "address_1": "4628 W Skyhawk Dr", "address_2": "N/A", "postal_code": "84084-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0292-2019", "product_description": "BeeGentle Honey Flavored Topical Anesthetic, Active ingredient Benzocaine 20%. Packaged in: a) Introductory Kit. Net Qty 3-3cc preloaded syringes.  . NDC# 1406000203 UPC 8 72320 00074 5 b) Bulk Kit Net Qty 30mL, NDC# 1406000202, UPC 8 72320 00076 9. Manufactured by CAO (China) Medical Equipment Co. Ltd. for CAO Group, Inc. 4628 West Skyhawk Drive, West Jordan, UT 84084", "product_quantity": "803 units (400 kit and 403 30 ml bottles)", "reason_for_recall": "cGMP violations noted during the firm's most recent inspection.", "recall_initiation_date": "20181116", "center_classification_date": "20181211", "termination_date": "20200227", "report_date": "20181219", "code_info": "Lots #: a) 110216, EXP 11/02/18; 170524, EXP 5/24/2019; 171116, EXP 11/16/2019; 180319, EXP 3/19/2020;  b)110216, EXP 11/02/2018;  170323, EXP 3/23/2019; 180109, EXP 1/09/2020"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207777"], "brand_name": ["APREPITANT"], "generic_name": ["APREPITANT"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-112", "68462-583", "68462-584", "68462-585"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_id": ["8cd02309-4a56-4a33-bc8f-f4c39edbf36a"], "spl_set_id": ["d72e0e10-4557-41b0-b65d-d395468cad19"], "package_ndc": ["68462-583-11", "68462-583-85", "68462-583-40", "68462-584-58", "68462-584-40", "68462-584-76", "68462-585-40", "68462-585-76", "68462-112-33", "3684625834"], "is_original_packager": [true], "upc": ["0368462585764", "0368462112335", "0368462584767", "0368462583401", "368462583401"], "nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "unii": ["1NF15YR6UY"]}, "product_type": "Drugs", "event_id": "81639", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0349-2019", "product_description": "Aprepitant Capsules, USP 40 mg,  1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40", "product_quantity": "5,016 blister packs", "reason_for_recall": "Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.", "recall_initiation_date": "20181127", "center_classification_date": "20190107", "termination_date": "20190912", "report_date": "20181226", "code_info": "Lot: 17180918, EXP June 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81458", "recalling_firm": "Sciegen Pharmaceuticals Inc", "address_1": "89 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0269-2019", "product_description": "Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755.  Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.", "product_quantity": "5,989 HDPE", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181029", "center_classification_date": "20181120", "termination_date": "20230925", "report_date": "20181128", "code_info": "69367-121-01 Irbesartan 300mg Tablets, 30 count bottle B162008A Sep-19   C162002A Feb-20   69367-121-03 Irbesartan 300mg Tablets, 90 count bottle B162008B Sep-19   C162002B Feb-20", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81120", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Hawaii and Puerto Rico.", "recall_number": "D-0244-2019", "product_description": "Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02", "product_quantity": "1,362 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing", "recall_initiation_date": "20180927", "center_classification_date": "20181114", "termination_date": "20201006", "report_date": "20181121", "code_info": "Lot # 31323147B, exp. date 01/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0059-2019", "product_description": "Best Choice, SALINE Nasal Spray (Sodium Chloride 0.65% Phenylcarbinol & Benzalkonium Chloride as Preservatives), 1.5 FL OZ (44 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC 0 70038 58487 2.", "product_quantity": "30,096 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0062-2019", "product_description": "Well at Walgreens, ULTRA FINE Sinus Relief Mist (Oxymetazoline HCl 0.05%) bottle, Sinus Reliever, Nasal Decongestant, 12 Hour Pump Mist, 0.5 FL OZ (15 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-7000-01, UPC 3 11917 18535 4.", "product_quantity": "361,104 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81020", "recalling_firm": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "address_1": "508 Carnegie Ctr", "address_2": "", "postal_code": "08540-6259", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0018-2019", "product_description": "treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs Abilify Tablets 10 mg (14 day supply) plus 1 Abilfy Maintena Vial Kit.Rx only. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA Marketed by: Lundbleck, Deerfield, IL 60015 USA Bar Code VialKit-59148-10Tabs-02", "product_quantity": "4738 kits", "reason_for_recall": "Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.", "recall_initiation_date": "20180917", "center_classification_date": "20181012", "termination_date": "20220309", "report_date": "20181010", "code_info": "Lots: 7F92YUD3H1A/ACS1616B, EXP 31-Jul-2019; F92YUD3H1A/ACS0118C, EXP 30-Jun-2020.", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0046-2019", "product_description": "Premier Value, Sterile Saline Nasal Mist, Saline Nasal Moisturizer (0.9% Sodium Chloride) Solution, 4.25 FL OZ (126 mL) can, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 8 40986 02998 1.", "product_quantity": "10,584 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Garden Grove", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81512", "recalling_firm": "Kadesh International", "address_1": "9618 Garden Grove Blvd Ste 201", "address_2": "", "postal_code": "92844-1565", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed via online stores and retail distributors Nationwide in the USA, Uruguay, Canada, China, Dominican Republic, Korea, and Vietnam.", "recall_number": "D-0250-2019", "product_description": "puriton EYE RELIEF DROPS, 0.5 oz (15 ml) bottle, Kadesh Inc., NDC#7079600115, UPC 7 36972 16799 0.", "product_quantity": "18,521 bottles", "reason_for_recall": "Non-Sterility: Product manufactured under non-sterile production conditions.", "recall_initiation_date": "20181105", "center_classification_date": "20181119", "termination_date": "20230124", "report_date": "20181121", "code_info": "All lots, no expiration dates are on the bottles.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0147-2019", "product_description": "Calcium Gluconate1% Eyewash 10 mg/mL, 125 mL bottles,  Pharm D Solutions, Houston, Texas ---- NDC 69699-0906-12", "product_quantity": "29 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 05072018:46 Discard by: 5/1/2019; 07122018:30 Discard by: 7/7/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0051-2019", "product_description": "Rite Aid Pharmacy, nasal relief NO DRIP PUMP SPRAY nasal spray, (oxymetazoline hydrochloride 0.05%), 12 Hour, 1 FL OZ (30 mL) bottle, Distributed By: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011, UPC 0 11822 31412 1.", "product_quantity": "114,336 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0141-2019", "product_description": "Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL), Pharm D Solutions, Houston, Texas --- NDC 69699-1323-05", "product_quantity": "130 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 04112018:34 Discard by: 10/7/2018; 08012018:66 Discard by: 1/28/2019; 07262018:34 Discard by: 1/8/2019"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81553", "recalling_firm": "AMERICAN HEALTH PACKAGING", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0273-2019", "product_description": "Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Blisters, Rx only, Amerisource Health Services DBA American Health Packaging, 2550-A John  Glenn Avenue Columbus, OH 43217, NDC 68084-446-01 (Individual Dose NDC: 68064-446-11)", "product_quantity": "4508 blister packs", "reason_for_recall": "Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that \"These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation.\"", "recall_initiation_date": "20181109", "center_classification_date": "20181120", "termination_date": "20200930", "report_date": "20181128", "code_info": "Lot#: 180310, 180612, Exp 03/31/20", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots; C262 BUD: 12/20/2018; D067 BUD: 03/21/2019; D072 BUD: 03/28/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 10mg pellet, 1 count (NDC 69761-010-01), 6 count (NDC 69761-010-06), 12 count (NDC 69761-010-12), and 30 count (NDC 69761-010-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0225-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "address_2": "", "product_quantity": "247 bottles", "code_info": "Lot K022216C", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Healthful Naturals Leg Cramp Support Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906  NDC 68703-206-02", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0256-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0073-2019", "product_description": "CVS Health, Original Strength, Triple Antibiotic Ointment Spray (bacitracin zinc 400 units, neomycin sulfate 3.5 mg, polymyxin B sulfate 5,000 units per gram), 2 OZ (57 g) can, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, Product#957603, UPC 0 50428 29525 0.", "product_quantity": "11,016 cans", "reason_for_recall": "Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 170591E, Exp. 11/17/18"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0323-2019", "product_description": "Amlodipine and Valsartan Tablets, USP 10/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., NDC 0378-1724-93.", "product_quantity": "84,066 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers:  3066064, 3069645, 3069646, 3073142, 3073143, 3073144, 3077617"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81351", "recalling_firm": "Promise Pharmacy LLC", "address_1": "31818 US Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide.", "recall_number": "D-0239-2019", "product_description": "Prednisolone and Gatifloxacin Ophthalmic Solution, 1%/0.5%, 3 mL dropper bottle, Rx Only, 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "N/A", "reason_for_recall": "Presence of precipitate", "recall_initiation_date": "20181018", "center_classification_date": "20181108", "termination_date": "20201022", "report_date": "20181031", "code_info": "Lot#: 04092018@2, Exp 12/03/2018"}, {"country": "United States", "city": "Upper Darby", "address_1": "6801 Ludlow St", "reason_for_recall": "Superpotent Drug: contains higher levels of Iron than labeled.", "address_2": "", "product_quantity": "1,155 boxes", "code_info": "Batch #: 579602, 579604, 579606, Exp 12/18; 579609, Exp 04/19.", "center_classification_date": "20181217", "distribution_pattern": "Nationwide in the USA.", "state": "PA", "product_description": "Monsel's (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA  19082, NDC 10481-0112-8.", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Gordon Laboratories", "recall_number": "D-0338-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81719", "termination_date": "20201202", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "19082-2408", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Florham Park", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA079102"], "brand_name": ["ALTAVERA"], "generic_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Xiromed, LLC."], "product_ndc": ["70700-116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "748878", "1006065"], "spl_id": ["cd0fbf86-78dd-a8f2-7399-112a042ab767"], "spl_set_id": ["4701e72b-6378-a771-fb88-1b703031a8bc"], "package_ndc": ["70700-116-85", "70700-116-84"], "is_original_packager": [true], "upc": ["0370700116852"]}, "product_type": "Drugs", "event_id": "81044", "recalling_firm": "Xiromed LLC", "address_1": "180 Florham Park", "address_2": "Suite 101", "postal_code": "07932", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0016-2019", "product_description": "Altavera Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg, Rx only, 3 tablet dispensers x 28 tablets. Manufactured by Laboratories Leon Farma S.A., Spain, for Xiromed, LLC., Florham Park, NJ 07932. Product of Spain NDC 70700-116-85 (I unit x 28 tablets 70700-116-84)", "product_quantity": "40064 3x28  units", "reason_for_recall": "Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.", "recall_initiation_date": "20180918", "center_classification_date": "20181011", "termination_date": "20190326", "report_date": "20181017", "code_info": "Lots: LF11838A Expiry May 2020; LF12107A, LF12106A, Expiry June 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0028-2019", "product_description": "Rhinall (phenylephrine hydrochloride) Nasal Decongestant Nose Drops, 0.25%, 1 FL OZ (30 mL) bottle, Distributed by: Scherer Labs International, LLC., 330 Carswell Ave., Daytona Beach, FL 32117, UPC 3 02747 52531 1.", "product_quantity": "4040 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0166-2019", "product_description": "Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution Compound Injectable NDC 69699-1603-30, Pharm D Solutions, Houston, Texas", "product_quantity": "896 vials; 64000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a) 09042018:66/A Discard by: 3/3/2019; 07302018:65 Discard by: 1/26/2019; b) 08132018:75/A Discard by: 2/1/2019; 04172018:16  Discard by: 9/30/2018; 03212018:27 Discard by: 9/17/2018; 04242018:82 Discard by: 10/20/2018; 05142018:72 Discard by: 11/10/2018; 06192018:67 Discard by: 12/18/2018; 08142018:00 Discard by: 2/1/2019; 07302018:64 Discard by: 1/26/2019"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["SPARKLEFRESH"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-083"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["27d69435-782e-9b40-e063-6394a90a93f4"], "spl_set_id": ["1565528b-89f2-4c97-b294-15b6ebd3f80e"], "package_ndc": ["53329-083-21", "53329-083-92", "53329-083-93", "53329-083-94", "53329-081-93"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "81381", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0247-2019", "product_description": "SparkleFresh Fluoride Toothpaste, Sodium Monofluorophosphate 0.76%, a) 17 g tube (NDC 53329-083-92, product number NONTP6I), b) 24 g tube (NDC 53329-083-93, product number NONTP85I), c) 42.5 g (NDC 53329-083-21, product number NONTP15I), d) 24 g tube (NDC 53329-081-93, product number DGN1000), Made in Malaysia for Medline Industries, Inc., Three Lakes Drive, Northfield, IL 60093 USA", "product_quantity": "994,756 tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "recall_initiation_date": "20180917", "center_classification_date": "20181115", "termination_date": "20200904", "report_date": "20181114", "code_info": "a) Lot 102920C, exp 10/29/2020 and 111220C, exp 11/11/2020; b) 111620D, exp 11/16/2020; c) 111420D, exp 11/14/2020;  d) 111720C, exp 11/17/2020", "more_code_info": ""}, {"country": "United States", "city": "Nicholasville", "address_1": "200 Moore Dr", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration Date; vial indicates a 1 year expiration date instead of a 6 month expiration date", "address_2": "", "product_quantity": "10,280 Vials", "code_info": "Lot, exp: 7101804, 7111807, 7131807, 7151801, 7161804, 7181805, 7191801, 7201803, 7211801, 7221801, 7231805, 7241803, 7251803, 7261802, 7271801, 7281801, 7301805, 7311805, exp 7/19;  8021801, 8031801, 8041801, 8081802, 8091804, 8101803, 8111810, 8121801, 8141801, 8161803, 8171803, 8201801, 8251801, exp 8/19", "center_classification_date": "20181107", "distribution_pattern": "Nationwide USA", "state": "KY", "product_description": "Tesamorelin, 1mg/vial, 6mL vial, Lyophilized Powder for Reconstitution and Subcutaneous Injection, Rx Only, Tailor Made Compounding, Nicholasville, KY 40356", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Tailor Made Compounding", "recall_number": "D-0223-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81337", "termination_date": "20190821", "more_code_info": "", "recall_initiation_date": "20180928", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Boca Raton", "address_1": "6111 Broken Sound Pkwy NW Ste 170", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.", "address_2": "", "product_quantity": "9,193 bottles", "code_info": "Lot #: 5599.008A,  5599.009A, 5599.010A, Exp. 04/2019;    5599.012A,  5599.013A, Exp. 11/2019;  5599.014A, Exp. 01/2020", "center_classification_date": "20181120", "distribution_pattern": "Nationwide within the United States", "state": "FL", "product_description": "Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "recall_number": "D-0279-2019", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "81523", "termination_date": "20191126", "more_code_info": "", "recall_initiation_date": "20181106", "postal_code": "33487-2875", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81020", "recalling_firm": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "address_1": "508 Carnegie Ctr", "address_2": "", "postal_code": "08540-6259", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0017-2019", "product_description": "treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850. Marketed by: Deerfield, IL 60015 USA. Bar Code DCSKit-59148-10Tabs-01", "product_quantity": "17325 kits", "reason_for_recall": "Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.", "recall_initiation_date": "20180917", "center_classification_date": "20181012", "termination_date": "20220309", "report_date": "20181010", "code_info": "Lots: 7F92YUD3H1A/AIS1017B,  7F92YUD3H1A/AIS1017C, EXP 30-Jun-2020.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0171-2019", "product_description": "Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1432-10", "product_quantity": "630 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08082018:86 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Maple Grove", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209916"], "brand_name": ["BUMETANIDE"], "generic_name": ["BUMETANIDE"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-0540", "0832-0541", "0832-0542"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUMETANIDE"], "rxcui": ["197417", "197418", "197419"], "spl_id": ["d53166d9-64ca-4b76-81a7-b70a60c53b12"], "spl_set_id": ["ff5dc8c6-b2f2-41d3-8e56-a953aa721b59"], "package_ndc": ["0832-0540-11", "0832-0541-11", "0832-0541-10", "0832-0542-11", "0832-0542-10"], "is_original_packager": [true], "upc": ["0308320540115", "0308320541112"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["0Y2S3XUQ5H"]}, "product_type": "Drugs", "event_id": "81174", "recalling_firm": "Upsher Smith Laboratories, Inc.", "address_1": "6701 Evenstad Dr N", "address_2": "N/A", "postal_code": "55369-6026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico and Guam", "recall_number": "D-0280-2019", "product_description": "Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by:  Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11", "product_quantity": "44,764 bottles", "reason_for_recall": "Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.", "recall_initiation_date": "20180919", "center_classification_date": "20181121", "termination_date": "20200930", "report_date": "20181031", "code_info": "Lot#:  375716, Exp 4/30/2020; 372957, 372958, 372959, Exp 3/31/2020; 374541, 375717, 376688, Exp 5/31/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0203-2019", "product_description": "Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1388-05", "product_quantity": "40 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05312018:12 Discard by: 11/27/2018; 07242018:04 Discard by: 1/20/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0035-2019", "product_description": "CVS Health, Saline Nasal Spray, 1.5 FL OZ bottle, Distributed by CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, Product #277790.", "product_quantity": "552 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "67 bottles", "code_info": "Lot K061417B", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies VertiFree Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-253-02", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0251-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Olive Branch", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81668", "recalling_firm": "Westminster Pharmaceuticals Llc", "address_1": "1 & 2", "address_2": "154 Downing Street", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0301-2019", "product_description": "Westminster Irbesartan Tablets, USP 150 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-120-01; b) 90 count bottle NDC 69367-120-03", "product_quantity": "2319 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed traces of NDEA  impurity in specific lots of Irbesartan.", "recall_initiation_date": "20181029", "center_classification_date": "20181214", "termination_date": "20211026", "report_date": "20181219", "code_info": "Batch Numbers: a) B161005A Exp. 09/30/2019, C161002A Exp. 02/29/2020; b) B161005B Exp. 09/30/2019, C161002B Exp. 02/29/2020"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0086-2019", "product_description": "Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. (42 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875519155", "product_quantity": "5,016 tubes", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 172185F, Exp 6/19"}, {"country": "United States", "city": "Princeton", "address_1": "100 College Rd W", "reason_for_recall": "Cross Contamination with Other Products", "address_2": "", "product_quantity": "7817 bottles", "code_info": "Lot #: HZ7896, Exp. 05/2021", "center_classification_date": "20181120", "distribution_pattern": "Nationwide within the United States", "state": "NJ", "product_description": "Isosorbide Dinitrate Tablets, USP 5 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories,  NDC 68001-223-00", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Sandoz Inc", "recall_number": "D-0259-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81457", "termination_date": "20201002", "more_code_info": "", "recall_initiation_date": "20181102", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0101-2019", "product_description": "Metformin Hydrochloride Extended Release Tablets 1000 mg, 90-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL, 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 , NDC 00591-2412-19", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: 1240400A, Exp 05/2019; 1293935M, Exp 12/2019"}]